Section Arrow
Quote
OGN.NYSE
- Organon & Co
Quotes are at least 15-min delayed:2026/04/25 04:13 EDT
Regular Hours
Last
 11.26
+2.66 (+30.93%)
Day High 
11.58 
Prev. Close
8.6 
1-M High
9.83 
Volume 
31.88M 
Bid
11.3
Ask
11.38
Day Low
9.955 
Open
10.745 
1-M Low
5.69 
Market Cap 
2.24B 
Currency 美元 
P/E 11.87 
%Yield 0.71 
10-SMA 9.02 
20-SMA 7.56 
50-SMA 7.15 
52-W High 13.245 
52-W Low 5.69 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.72/6.50
Enterprise Value
10.87B
Balance Sheet
Book Value Per Share
2.89
Cash Flow
Cash Flow Yield
0.31
Income Statement
Total Revenue
6.22B
Operating Revenue Per Share
23.63
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFEPfizer27+0.33+1.24%19.61PE
OGNOrganon & Co11.26+2.66+30.93%11.87PE
NVONovo-Nordisk A/S41.17+2.65+6.88%10.72PE
ABBVABBVIE198.71-2.24-1.11%84.84PE
MRKMerck & Co111.9-2.72-2.37%15.67PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.